Plenary Presentation to be Followed by Poster Presentation Highlighting HLD-0915 Clinical DataBOSTON, Oct. 14, 2025 (GLOBE ...

PulseSight Therapeutics, a clinical stage ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology welcomes the publication of new ...

Abstract: Few-Shot Object Detection (FSOD) aims to detect the objects of novel classes using only a few manually annotated samples. With the few novel class samples, learning the inter-class ...